What Has Been the Progress and Growth of the Cell Transfection Market in Recent Years?
The cell transfection market has seen considerable growth due to a variety of factors.
• The market for cell transfection has seen robust growth in the past few years. There is a projected increase from $1.29 billion in 2024 to $1.42 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 9.4%.
This growth during the historic period can be traced back to a surge in gene editing studies using techniques like CRISPR, increased funding from governmental and non-governmental sources, rising number of clinical trials involving transfected cells, an expanding academia in the field of molecular biology, and an increasing trend towards high-throughput screening methods.
What Can Be Expected from the Cell Transfection Market Size?
The cell transfection market is expected to maintain its strong growth trajectory in upcoming years.
• The size of the cell transfection market is poised for potent growth in the upcoming years. It's projected to increase to $2 billion in 2029, equating to a compound annual growth rate (CAGR) of 9.0%.
The expansion predicted in the forecast timeframe is due to factors such as increased demand for gene therapy, a rise in chronic ailments, the growth of the biopharmaceutical sector, progress in proteomics and genomics studies, and an increase in RNA-based therapeutics applications. Key trends predicted during the forecast period include heightened investment in biotech and pharmaceutical research and development, advancements in transfection technologies, the advent of personalized medicine, the application of transfection in cancer studies, and the creation of new transfection reagents and kits.
What Are the Critical Driver Fuelling The Cell Transfection Market's Growth?
The rise in infectious disease cases is anticipated to fuel the cell transfection market's expansion. Germs cause infectious diseases that can spread from person to person or through tainted sources. Factors like poor public health infrastructure, reluctance to get vaccinated, and misinformation have contributed to the spread and evolution of pathogens. For studying the impact of infections on cells and evaluating new treatments, cell transfection serves as an effective instrument. As per a September 2023 report by the Australian Bureau of Statistics, a government agency in Australia, the death rate associated with influenza and pneumonia was 31.5 per 100,000 in 2021, which escalated to 42.6 per 100,000 in 2022. Thus, the surge in the cases of infectious diseases propels the cell transfection market.
How Is The Cell Transfection Market segmented?
The cell transfectionmarket covered in this report is segmented –
1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods
2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users
Subsegments:
1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation
2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection
3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods
4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction
5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection
Pre-Book The Cell Transfection Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Cell Transfection Market?
Leading companies in the cell transfection marketplace are incorporating innovations into their transfection systems to ensure accurate control over gene expression. Transfection systems, which involve the introduction of external nucleic acids into cells for studying gene functionality, protein production, or gene expression alteration, are being updated. For instance, the Canada-based biotech company STEMCELL Technologies introduced the Cellpore transfection system in July 2024. This innovative tool, developed to boost cell engineering research, uses superior microfluidic technology for the intracellular delivery of numerous macromolecules into cells, providing solutions to the constraints of conventional transfection processes. Capable of transfecting up to 10 million cells per second, it underscores its potential for large-scale applications. It aligns with different cell types, including T cells and hematopoic stem cells. Moreover, it can transport an array of cargoes, including small molecules, RNA, proteins, and antibodies.
Who Are the Key Players In The Cell Transfection Market?
Major companies operating in the cell transfection market are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies Inc.
• Lonza Group AG
• Sartorius AG
• Sigma-Aldrich Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Stemcell Technologies Inc.
• GenScript Biotech Corporation
• Promega Corporation
• Takara Bio Inc.
• Molecular Devices LLC
• New England Biolabs Inc.
• CureVac SE
• OriGene Technologies Inc.
• Tocris Bioscience
• Vector Biolabs
• Mirus Bio LLC
• Addgene Inc.
• Altogen Biosystems
• Cell Biolabs Inc.
• Cellecta Inc.
• ExCell Bio Inc.
• GeneCopoeia Inc.
What Is The Most Dominant Region In The Cell Transfection Market?
North America was the largest region in the cell transfection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
